IBDscope – Evolving algorithms for IBD: What Drives choice?
The shared decision making model is a complex network of relationships among the patient, provider, and payer. Dr. Rubin uses an ethical framework to discuss how to take patients’ expectations into account when devising a treatment plan.
Click here to register and watch the entire webinar.
SEQUENCING THERAPIES FOR IBD
With the vast options for IBD therapies in our modern world, which therapy is the right choice? Dr. Rubin discusses a treat to target strategy to monitor disease, optimize treatment, and guide adjustments to the treatment plan.
DE-ESCALATION OF IBD TREATMENT
De-escalation of IBD treatment is an important topic, not only because patients frequently ask when they can stop their therapies, but also in consideration of the costs of therapies, long-term exposures of therapies, and in the chronic management of a condition like Crohn’s disease or ulcerative colitis.
CANCER PREVENTION IN IBD
Prevention of cancer in patients with IBD requires understanding the risk factors, educating patients, incorporating regular screenings, and considering the risk in conjunction with the risk of IBD progression.
INFLAMMATORY BOWEL DISEASE FOR RHEUMATOLOGISTS
Dr. Rubin discusses when to suspect IBD in patients with rheumatological conditions, and the relationship among IBD and rheumatology along the gut-synovial axis.
MANAGEMENT OF CROHN’S DISEASE
Dr. Rubin goes over the importance of early diagnosis and effective treatment for patients with Crohn’s Disease, the goals of management, available therapies, the need for monitoring, and how to prevent complications.
HIGH RISK ULCERATIVE COLITIS: WHERE DO WE START?
Dr. Rubin discusses treatment options for patients with high risk ulcerative colitis, the importance of treating aggressively to achieve stable control, how to rule out infections and drug intolerance, and when to discuss surgery.